Terms: = Breast cancer AND U2AF1, ENSG00000160201, 7307, Q01081, U2AFBP, U2AF35, RNU2AF1, RN, FP793, DKFZp313J1712
61 results:
1. Activation of ERβ hijacks the splicing machinery to trigger R-loop formation in triple-negative breast cancer.
Wang D; Tang M; Zhang P; Yang K; Huang L; Wu M; Shen Q; Yue J; Wang W; Gong Y; Warner M; Dai L; He H; Yang Z; Gustafsson JA; Zhou S
Proc Natl Acad Sci U S A; 2024 Mar; 121(13):e2306814121. PubMed ID: 38513102
[TBL] [Abstract] [Full Text] [Related]
2. Simultaneous evaluation of brain metastasis and thoracic cancer using semiconductor
Kaneko K; Nagao M; Ueda K; Yamamoto A; Sakai S
Ann Nucl Med; 2024 Apr; 38(4):278-287. PubMed ID: 38386272
[TBL] [Abstract] [Full Text] [Related]
3. Pan-tumor survey of ROS1 fusions detected by next-generation RNA and whole transcriptome sequencing.
Nagasaka M; Zhang SS; Baca Y; Xiu J; Nieva J; Vanderwalde A; Swensen JJ; Spetzler D; Korn WM; Raez LE; Liu SV; Ou SI
BMC Cancer; 2023 Oct; 23(1):1000. PubMed ID: 37853341
[TBL] [Abstract] [Full Text] [Related]
4. Linear Regression Modeling Based Scoring System to Reduce Benign breast Biopsies Using Multi-parametric US with Color Doppler and SWE.
Demirci BÖ; Buğdaycı O; Ertaş G; Şanlı DET; Kaya H; Arıbal E
Acad Radiol; 2023 Sep; 30 Suppl 2():S143-S153. PubMed ID: 36804295
[TBL] [Abstract] [Full Text] [Related]
5. Design, synthesis, characterizing and DFT calculations of a binary CT complex co-crystal of bioactive moieties in different polar solvents to investigate its pharmacological activity.
Islam M; Khan IM; Shakya S; Alam N
J Biomol Struct Dyn; 2023 Dec; 41(20):10813-10829. PubMed ID: 36579428
[TBL] [Abstract] [Full Text] [Related]
6. Stereoselective synthesis of oxime containing Pd(II) compounds: highly effective, selective and stereo-regulated cytotoxicity against carcinogenic PC-3 cells.
de la Cueva-Alique I; de la Torre-Rubio E; Muñoz-Moreno L; Calvo-Jareño A; Pérez-Redondo A; Gude L; Cuenca T; Royo E
Dalton Trans; 2022 Aug; 51(34):12812-12828. PubMed ID: 35796301
[TBL] [Abstract] [Full Text] [Related]
7. Mapping of PET/CT-based regional nodes distribution of recurrent/advanced breast cancer and comparison with current delineation atlas.
Zhang M; Cao L; Chen J; Li B; Huang X; Cai G; Xu C
Br J Radiol; 2022 Sep; 95(1137):20220382. PubMed ID: 35731844
[TBL] [Abstract] [Full Text] [Related]
8. Trastuzumab emtansine increases the risk of stereotactic radiosurgery-induced radionecrosis in HER2 + breast cancer.
Id Said B; Chen H; Jerzak KJ; Warner E; Myrehaug S; Tseng CL; Detsky J; Husain Z; Sahgal A; Soliman H
J Neurooncol; 2022 Aug; 159(1):177-183. PubMed ID: 35715667
[TBL] [Abstract] [Full Text] [Related]
9. Environmental/Occupational Exposure to Radon and Non-Pulmonary Neoplasm Risk: A Review of Epidemiologic Evidence.
Mozzoni P; Pinelli S; Corradi M; Ranzieri S; Cavallo D; Poli D
Int J Environ Res Public Health; 2021 Oct; 18(19):. PubMed ID: 34639764
[TBL] [Abstract] [Full Text] [Related]
10. Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis.
Salvo EM; Ramirez AO; Cueto J; Law EH; Situ A; Cameron C; Samjoo IA
Breast; 2021 Jun; 57():5-17. PubMed ID: 33677313
[TBL] [Abstract] [Full Text] [Related]
11. [Clinical analysis of 12 cases of acute myeloid leukemia complicated with synchronous primary solid tumor].
Mi RH; Dang HB; Chen L; Han YL; Wang MF; Zhang YL; Chen L; Li DB; Wei XD
Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(42):3323-3327. PubMed ID: 33202495
[No Abstract] [Full Text] [Related]
12. Considerations for feature selection using gene pairs and applications in large-scale dataset integration, novel oncogene discovery, and interpretable cancer screening.
Moody L; Chen H; Pan YX
BMC Med Genomics; 2020 Oct; 13(Suppl 10):148. PubMed ID: 33087122
[TBL] [Abstract] [Full Text] [Related]
13. Tumor microenvironment-responsive polymer with chlorin e6 to interface hollow mesoporous silica nanoparticles-loaded oxygen supply factor for boosted photodynamic therapy.
Wang X; Ding X; Yu B; Zhang X; Shen Y; Cong H
Nanotechnology; 2020 Jul; 31(30):305709. PubMed ID: 32299065
[TBL] [Abstract] [Full Text] [Related]
14. Generation and Characterization of Patient-Derived Head and Neck, Oral, and Esophageal cancer Organoids.
Karakasheva TA; Kijima T; Shimonosono M; Maekawa H; Sahu V; Gabre JT; Cruz-Acuña R; Giroux V; Sangwan V; Whelan KA; Natsugoe S; Yoon AJ; Philipone E; Klein-Szanto AJ; Ginsberg GG; Falk GW; Abrams JA; Que J; Basu D; Ferri L; Diehl JA; Bass AJ; Wang TC; Rustgi AK; Nakagawa H
Curr Protoc Stem Cell Biol; 2020 Jun; 53(1):e109. PubMed ID: 32294323
[TBL] [Abstract] [Full Text] [Related]
15. The core spliceosomal factor u2af1 controls cell-fate determination via the modulation of transcriptional networks.
Laaref AM; Manchon L; Bareche Y; Lapasset L; Tazi J
RNA Biol; 2020 Jun; 17(6):857-871. PubMed ID: 32150510
[TBL] [Abstract] [Full Text] [Related]
16. Comparison of two-stage Gamma Knife radiosurgery outcomes for large brain metastases among primary cancers.
Ito D; Aoyagi K; Nagano O; Serizawa T; Iwadate Y; Higuchi Y
J Neurooncol; 2020 Mar; 147(1):237-246. PubMed ID: 32026433
[TBL] [Abstract] [Full Text] [Related]
17. ARX788, a novel anti-HER2 antibody-drug conjugate, shows anti-tumor effects in preclinical models of trastuzumab emtansine-resistant HER2-positive breast cancer and gastric cancer.
Barok M; Le Joncour V; Martins A; Isola J; Salmikangas M; Laakkonen P; Joensuu H
Cancer Lett; 2020 Mar; 473():156-163. PubMed ID: 31904483
[TBL] [Abstract] [Full Text] [Related]
18. Optimal Target Delineation and Treatment Techniques in the Era of Conformal Photon and Proton breast and Regional Nodal Irradiation.
Kowalski ES; Feigenberg SJ; Cohen J; Fellows Z; Vadnais P; Rice S; Mishra MV; Molitoris JK; Nichols EM; Snider JW
Pract Radiat Oncol; 2020; 10(3):174-182. PubMed ID: 31786234
[TBL] [Abstract] [Full Text] [Related]
19. Water soluble, optically active monofunctional Pd(ii) and Pt(ii) compounds: promising adhesive and antimigratory effects on human prostate PC-3 cancer cells.
de la Cueva-Alique I; Muñoz-Moreno L; de la Torre-Rubio E; Bajo AM; Gude L; Cuenca T; Royo E
Dalton Trans; 2019 Oct; 48(38):14279-14293. PubMed ID: 31482936
[TBL] [Abstract] [Full Text] [Related]
20. Improving Wait Times and Patient Experience Through Implementation of a Provincial Expedited Diagnostic Pathway for BI-RADS 5 breast Lesions.
Laws A; Crocker A; Dort J; Olson D; Elwi A; Anderes S; Parker S; Estey A; Keehn A; Quan ML
Ann Surg Oncol; 2019 Oct; 26(10):3361-3367. PubMed ID: 31342368
[TBL] [Abstract] [Full Text] [Related]
[Next]
